Literature DB >> 24757109

Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective.

Trevor W Robbins1, Roshan Cools.   

Abstract

Progress in characterization of the nature, neural basis, and treatment of cognitive deficits in Parkinson's disease is reviewed from the perspective of cognitive neuroscience. An initial emphasis on fronto-striatal executive deficits is surveyed along with the discoveries of disruption as well as remediation of certain impairments by dopaminergic mediation and their association with theories of reinforcement learning. Subsequent focus on large cohorts has revealed considerable heterogeneity in the cognitive impairments as well as a suggestion of at least two distinct syndromes, with the dopamine-dependent fronto-striatal deficits being somewhat independent of other signs commonly associated with Parkinson's disease dementia. The utility is proposed of a new, integrated cognitive neuroscience approach based on combining genetic and neuroimaging methodologies with neuropsychological and, ultimately, psychopharmacological approaches.
© 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  attention; cognition; dopamine; executive function; memory; prefrontal cortex; striatum

Mesh:

Year:  2014        PMID: 24757109     DOI: 10.1002/mds.25853

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  76 in total

Review 1.  Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review.

Authors:  Katherine Leaver; Kathleen L Poston
Journal:  Neuropsychol Rev       Date:  2015-12-01       Impact factor: 7.444

Review 2.  Impacts of dance on non-motor symptoms, participation, and quality of life in Parkinson disease and healthy older adults.

Authors:  M E McNeely; R P Duncan; G M Earhart
Journal:  Maturitas       Date:  2015-08-12       Impact factor: 4.342

Review 3.  Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?

Authors:  Paolo Calabresi; Veronica Ghiglieri; Petra Mazzocchetti; Ilenia Corbelli; Barbara Picconi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

4.  Frontal lobe metabolic alterations characterizing Parkinson's disease cognitive impairment.

Authors:  Shefali Chaudhary; S Senthil Kumaran; Vinay Goyal; M Kalaivani; Gauri Shanker Kaloiya; Rajesh Sagar; Nalin Mehta; Achal Kumar Srivastava; N R Jagannathan
Journal:  Neurol Sci       Date:  2020-07-29       Impact factor: 3.307

5.  Introduction: the importance of cognition in movement disorders.

Authors:  David Burn; Daniel Weintraub; Trevor Robbins
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

6.  A model-based quantification of action control deficits in Parkinson's disease.

Authors:  Mathieu Servant; Nelleke van Wouwe; Scott A Wylie; Gordon D Logan
Journal:  Neuropsychologia       Date:  2018-01-29       Impact factor: 3.139

Review 7.  Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support.

Authors:  Samuel E Marsh; Mathew Blurton-Jones
Journal:  Neurochem Int       Date:  2017-02-20       Impact factor: 3.921

8.  Patients with Parkinson's Disease Show Impaired Use of Priors in Conditions of Sensory Uncertainty.

Authors:  Alessandra Perugini; Jochen Ditterich; Michele A Basso
Journal:  Curr Biol       Date:  2016-06-16       Impact factor: 10.834

9.  Optogenetic Stimulation of Frontal D1 Neurons Compensates for Impaired Temporal Control of Action in Dopamine-Depleted Mice.

Authors:  Young-Cho Kim; Sang-Woo Han; Stephanie L Alberico; Rafael N Ruggiero; Benjamin De Corte; Kuan-Hua Chen; Nandakumar S Narayanan
Journal:  Curr Biol       Date:  2016-12-15       Impact factor: 10.834

10.  Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson's disease.

Authors:  Kazuya Kawabata; Hirohisa Watanabe; Kazuhiro Hara; Epifanio Bagarinao; Noritaka Yoneyama; Aya Ogura; Kazunori Imai; Michihito Masuda; Takamasa Yokoi; Reiko Ohdake; Yasuhiro Tanaka; Takashi Tsuboi; Tomohiko Nakamura; Masaaki Hirayama; Mizuki Ito; Naoki Atsuta; Satoshi Maesawa; Shinji Naganawa; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.